A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma.
Nylund P, Atienza Párraga A, Haglöf J, De Bruyne E, Menu E, Garrido-Zabala B, Ma A, Jin J, Öberg F, Vanderkerken K, Kalushkova A, Jernberg-Wiklund H.
Nylund P, et al.
Cell Death Dis. 2021 Feb 12;12(2):167. doi: 10.1038/s41419-021-03447-8.
Cell Death Dis. 2021.
PMID: 33579905
Free PMC article.